cafepharmaDec 11, 2023
Bluebird's newly approved SCD gene therapy faces rough road with hefty price tag, boxed warning-- How Kyowa Kirin is giving employees a voice in the company's future --Moderna, Merck begin late-stage study for mRNA cancer therapy --http://bit.ly/w28kSd #bluebirdbio #sicklecelldisease #kyowakirin #merck #moderna #cancer #mRNA #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma